NO20026168D0 - 3-azabicyclo (3.1.0) hexane derivatives with opioid receptor affinity - Google Patents

3-azabicyclo (3.1.0) hexane derivatives with opioid receptor affinity

Info

Publication number
NO20026168D0
NO20026168D0 NO20026168A NO20026168A NO20026168D0 NO 20026168 D0 NO20026168 D0 NO 20026168D0 NO 20026168 A NO20026168 A NO 20026168A NO 20026168 A NO20026168 A NO 20026168A NO 20026168 D0 NO20026168 D0 NO 20026168D0
Authority
NO
Norway
Prior art keywords
azabicyclo
opioid receptor
receptor affinity
hexane derivatives
hexane
Prior art date
Application number
NO20026168A
Other languages
Norwegian (no)
Other versions
NO20026168L (en
Inventor
Bernard Joseph
Douglas James Critcher
Ashley FENWICK
David Morris Gethin
Stephen Paul Gibson
Graham Lunn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20026168D0 publication Critical patent/NO20026168D0/en
Publication of NO20026168L publication Critical patent/NO20026168L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
NO20026168A 2000-06-23 2002-12-20 Hexane derivatives having opioid receptor affinity NO20026168L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015562.2A GB0015562D0 (en) 2000-06-23 2000-06-23 Heterocycles
PCT/IB2001/001035 WO2001098267A1 (en) 2000-06-23 2001-06-07 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity

Publications (2)

Publication Number Publication Date
NO20026168D0 true NO20026168D0 (en) 2002-12-20
NO20026168L NO20026168L (en) 2003-02-18

Family

ID=9894368

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026168A NO20026168L (en) 2000-06-23 2002-12-20 Hexane derivatives having opioid receptor affinity

Country Status (34)

Country Link
EP (1) EP1292574A1 (en)
JP (1) JP2004512263A (en)
KR (1) KR20040002386A (en)
CN (1) CN1639121A (en)
AP (1) AP2002002698A0 (en)
AR (1) AR028969A1 (en)
AU (1) AU781837B2 (en)
BG (1) BG107329A (en)
BR (1) BR0111867A (en)
CA (1) CA2412188A1 (en)
CZ (1) CZ20023967A3 (en)
DO (1) DOP2001000187A (en)
DZ (1) DZ3368A1 (en)
EA (1) EA005117B1 (en)
GB (1) GB0015562D0 (en)
HR (1) HRP20020998A2 (en)
HU (1) HUP0301228A3 (en)
IL (1) IL153427A0 (en)
IS (1) IS6637A (en)
MA (1) MA26915A1 (en)
MX (1) MXPA02012878A (en)
NO (1) NO20026168L (en)
NZ (1) NZ523141A (en)
OA (1) OA12293A (en)
PA (1) PA8519401A1 (en)
PE (1) PE20020253A1 (en)
PL (1) PL365956A1 (en)
SK (1) SK17172002A3 (en)
TN (1) TNSN01094A1 (en)
UA (1) UA73176C2 (en)
UY (1) UY26787A1 (en)
WO (1) WO2001098267A1 (en)
YU (1) YU91802A (en)
ZA (1) ZA200210278B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20084300B (en) * 2001-10-22 2008-02-11 Pfizer Prod Inc 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
AU2003242527B2 (en) * 2002-05-17 2008-10-23 Tioga Pharmaceuticals, Inc. Use of compounds that are effective as selective opiate receptor modulators
DE10259245A1 (en) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivatives of asimadolin with covalently bound acids
JP4960217B2 (en) 2004-02-23 2012-06-27 グラクソ グループ リミテッド Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE484502T1 (en) * 2005-06-14 2010-10-15 Glaxo Group Ltd NEW CONNECTIONS
US8163927B2 (en) 2006-04-03 2012-04-24 Glaxo Group Limited Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
CN101677997B (en) 2007-03-30 2012-05-09 泰奥加制药公司 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
TWI423801B (en) * 2007-08-27 2014-01-21 Theravance Inc 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
CA2936749C (en) 2010-06-11 2019-07-09 Joshua R. Giguere Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
US9133116B2 (en) 2010-09-28 2015-09-15 Panacea Biotec Ltd. Bicyclic compounds
ES2774349T3 (en) 2013-11-20 2020-07-20 Sanwa Kagaku Kenkyusho Co Derived from 3-azabicyclo [3.1.0] hexane and its use for medical purposes
US10392345B2 (en) 2015-05-20 2019-08-27 Sanwa Kagaku Kenkyusho Co., Ltd. Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof
US11702408B2 (en) 2017-02-17 2023-07-18 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110352055A (en) 2017-03-02 2019-10-18 株式会社三和化学研究所 The therapeutic agent of alcohol use disorders
CN108250088B (en) * 2018-01-04 2020-10-30 四川之江高新材料股份有限公司 Preparation method of N, N, N '-trimethyl-N' -hydroxyethyl bisaminoethylether

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065230A (en) * 1959-03-16 1962-11-20 Burroughs Wellcome Co Azabicyclohexanes and method of preparing them
AR245933A1 (en) * 1987-04-16 1994-03-30 Lilly Co Eli Piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
PE20001420A1 (en) * 1998-12-23 2000-12-18 Pfizer CCR5 MODULATORS

Also Published As

Publication number Publication date
CZ20023967A3 (en) 2004-02-18
WO2001098267A1 (en) 2001-12-27
ZA200210278B (en) 2003-12-19
UA73176C2 (en) 2005-06-15
AR028969A1 (en) 2003-05-28
KR20040002386A (en) 2004-01-07
TNSN01094A1 (en) 2005-11-10
HRP20020998A2 (en) 2004-02-29
MXPA02012878A (en) 2003-05-14
SK17172002A3 (en) 2004-09-08
NO20026168L (en) 2003-02-18
DOP2001000187A (en) 2002-03-30
YU91802A (en) 2006-05-25
AU781837B2 (en) 2005-06-16
HUP0301228A3 (en) 2005-08-29
HUP0301228A2 (en) 2003-08-28
PL365956A1 (en) 2005-01-24
CA2412188A1 (en) 2001-12-27
IS6637A (en) 2002-11-28
UY26787A1 (en) 2002-01-31
AP2002002698A0 (en) 2002-12-31
EA200201269A1 (en) 2003-06-26
BG107329A (en) 2003-07-31
WO2001098267A8 (en) 2003-02-27
NZ523141A (en) 2005-06-24
EP1292574A1 (en) 2003-03-19
AU6259101A (en) 2002-01-02
PE20020253A1 (en) 2002-04-08
GB0015562D0 (en) 2000-08-16
JP2004512263A (en) 2004-04-22
EA005117B1 (en) 2004-10-28
OA12293A (en) 2004-03-18
CN1639121A (en) 2005-07-13
BR0111867A (en) 2003-07-01
DZ3368A1 (en) 2001-12-27
PA8519401A1 (en) 2002-12-30
MA26915A1 (en) 2004-12-20
IL153427A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
HK1072052A1 (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
DE69928945D1 (en) 4,4-BIARYLPIPERIDINE DERIVATIVES WITH OPIOID RECEPTOR EFFECT
DE60214428D1 (en) 1, 4-DIHYDRO-1, 4-DIPHENYLPYRIDINE DERIVATIVES
DK1140828T3 (en) 3-Azabicyclo [3.1.0] hexane derivatives as opiate receptor ligands
DE60019577D1 (en) 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUM-AGENT
NO20026168D0 (en) 3-azabicyclo (3.1.0) hexane derivatives with opioid receptor affinity
NO20040198L (en) Dolastatin 10 derivatives
PL365377A1 (en) Amide derivatives as nmda receptor antagonists
DK1427709T3 (en) 3-substituted 4-pyrimidone derivatives
MXPA03006991A (en) Piperidinee derivatives as neurokinin 1 antagonists.
HK1051863A1 (en) Indol-3-yl derivatives.
DE50107988D1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDROCHINOLIN-2-CARBOXYLENE DERIVATIVES
HK1042699A1 (en) N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.
DE60025958D1 (en) 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE
AR028607A1 (en) DERIVATIVES OF 1,4-DIAZEPAN-2,5-DIONA
DE50008020D1 (en) SUBSTITUTED PYRROLIDIN-2,3,4-TRION DERIVATIVES EFFECTIVE AS NMDA RECEPTOR ANTAGONISTS
NO20030868L (en) N- (3,5-dichloro-2-methoxyphenyl) -4-methoxy-3-piperazin-1-yl-benzenesulfonamide
MA27240A1 (en) IMIDAZOQUINOLEIN DERIVATIVES
ZA200206140B (en) Heterocyclic amide Derivatives.
FR2824826B1 (en) NOVEL 5-CYANO-1H-INDOLE DERIVATIVES INTERLEUKIN-8 RECEPTOR ANTAGONISTS
AR027974A1 (en) 1-ARIL-CICLOPROPILMETILAMINO-1,3,5-SUBSTITUTED TRIAZINS
DK1175397T3 (en) 3,3-substituted indoline derivatives
IS7299A (en) 3,4-dihydro-1H-isoquinolone-2-yl derivatives
DE60017150D1 (en) 1,4,5,6-Tetra-Hydropropylidene-Derivatives as VITRONECTIN-INHIBITORS
DK1274687T3 (en) 1,2,3,4-tetrahydroisoquinoline derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application